Andon Health 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Yi Liu

최고 경영자

CN¥1.1m

총 보상

CEO 급여 비율	n/a
CEO 임기	17.4yrs
CEO 소유권	n/a
경영진 평균 재임 기간	6yrs
이사회 평균 재임 기간	4.9yrs

최근 관리 업데이트

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Nov 18

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Oct 16

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

May 08

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Mar 22

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

Mar 19

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Mar 01

CEO

Yi Liu (57 yo)

17.4yrs

테뉴어

CN¥1,069,600

보상

Mr. Yi Liu is Chairman & GM of Andon Health Co., Ltd. from June 16, 2007.

리더십 팀

이름	위치	테뉴어	보상	소유권
Yi Liu	Chairman & GM	17.4yrs	CN¥1.07m	데이터 없음
Yong Wang	Director & Deputy GM	4.9yrs	CN¥1.04m	0.057% CN¥ 11.4m
Ming Cong	Deputy GM & Director	4.4yrs	CN¥801.70k	0.057% CN¥ 11.4m
Tong Wu	Board Secretary	7.1yrs	CN¥408.80k	0.019% CN¥ 3.8m

6.0yrs

평균 재임 기간

43.5yo

평균 연령

경험이 풍부한 관리: 002432 의 관리팀은 노련하고 경험 (평균 재직 기간 6 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yi Liu	Chairman & GM	17.4yrs	CN¥1.07m	데이터 없음
Yong Wang	Director & Deputy GM	4.9yrs	CN¥1.04m	0.057% CN¥ 11.4m
Ming Cong	Deputy GM & Director	4.4yrs	CN¥801.70k	0.057% CN¥ 11.4m
Shuguang He	Independent Director	less than a year	CN¥13.30k	데이터 없음
Kai Yao	Supervisory Board Chairman	16.9yrs	데이터 없음	데이터 없음
Zhiqing Liu	Supervisor	10.9yrs	데이터 없음	데이터 없음
Xinhui Zhai	Supervisor	4.9yrs	데이터 없음	데이터 없음
Xiaofang Bi	Independent Director	3.5yrs	CN¥80.00k	데이터 없음
Weijun Sun	Independent Director	4.3yrs	CN¥80.00k	데이터 없음

4.9yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 이사회: 002432 의 이사회는 경험(평균 재직 기간 4.9 년)으로 간주됩니다.

Andon Health 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Insufficient new directors

Andon Health Co., Ltd., Annual General Meeting, May 21, 2024

Andon Health Co., Ltd., Annual General Meeting, May 22, 2023

Andon Health Co., Ltd. Announces Executive Changes

No independent directors

Andon Health Co., Ltd., Annual General Meeting, May 20, 2022

Recent updates

Andon Health Co., Ltd.'s (SZSE:002432) Earnings Are Not Doing Enough For Some Investors

Third quarter 2024 earnings released: EPS: CN¥1.85 (vs CN¥0.24 in 3Q 2023)

Andon Health (SZSE:002432) Is Doing The Right Things To Multiply Its Share Price

Andon Health Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 18%

These 4 Measures Indicate That Andon Health (SZSE:002432) Is Using Debt Safely

Second quarter 2024 earnings released: EPS: CN¥0.83 (vs CN¥0.39 in 2Q 2023)

Andon Health Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Market Cool On Andon Health Co., Ltd.'s (SZSE:002432) Earnings

Insufficient new directors

Dividend of CN¥0.30 announced

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 04 June 2024

Is Andon Health (SZSE:002432) Using Too Much Debt?

Andon Health's (SZSE:002432) Weak Earnings May Only Reveal A Part Of The Whole Picture

Investor sentiment improves as stock rises 17%

Andon Health Co., Ltd., Annual General Meeting, May 21, 2024

Andon Health Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Investor sentiment improves as stock rises 15%

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Investor sentiment improves as stock rises 20%

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 15%

Andon Health Co., Ltd. to Report Fiscal Year 2023 Results on Apr 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥1.77 in 3Q 2022)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 1,000 million worth of its shares.

Second quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥2.04 in 2Q 2022)

Now 20% undervalued after recent price drop

Andon Health Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 13 June 2023

Andon Health Co., Ltd. Approves Dividend for 2022

Andon Health Co., Ltd., Annual General Meeting, May 22, 2023

First quarter 2023 earnings released: EPS: CN¥1.28 (vs CN¥31.39 in 1Q 2022)

Andon Health Co., Ltd. Announces Executive Changes

No independent directors

Third quarter 2022 earnings released: EPS: CN¥1.77 (vs CN¥0.01 loss in 3Q 2021)

Andon Health Co., Ltd. Approves Cash Dividend for the Year 2021

Andon Health Co., Ltd. Proposes Final Cash Dividend for the Year 2021

Andon Health Co., Ltd., Annual General Meeting, May 20, 2022

First quarter 2022 earnings released: EPS: CN¥31.39 (vs CN¥0.085 in 1Q 2021)

Insufficient new directors

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: CN¥2.01 (vs CN¥0.56 in FY 2020)

Third quarter 2021 earnings released: CN¥0.01 loss per share (vs CN¥0.24 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.037 (vs CN¥0.49 in 2Q 2020)

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

Andon Health Co., Ltd. Announces 2020 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 03 June 2021

Andon Health Co., Ltd. Approves Cash Dividend for 2020

Third quarter 2020 earnings released: EPS CN¥0.24 (vs CN¥0.069 loss in 3Q 2019)

Andon Health Co., Ltd. Proposes Final Cash Dividend for 2020

Andon Health Co., Ltd. (SZSE:002432) announces an Equity Buyback for CNY 100 million worth of its shares.

New 90-day low: CN¥8.43

New 90-day low: CN¥9.27

New 90-day low: CN¥9.33

New 90-day low: CN¥10.26

New 90-day low - CN¥10.30

First half earnings released

Andon Health Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령